Archive for: ACA

  • ORIGINAL ANALYSIS

  • PDF DOWNLOAD

  • EXTERNAL LINK

  • POST

Insight: original analysis

McDermottPlus Check-Up: August 2, 2019

This Week’s Dose: Things have quieted down in Congress with the House out of session and the Senate wrapping up its last week before the August recess. But the agencies are still at work, so don’t totally check out just yet.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: July 19, 2019

This Week’s Dose: The Energy and Commerce Committee held a marathon mark-up of 25 bills, including 10 health care related bills. The No Surprises Act received an amendment that adds arbitration to the payment dispute process. The House voted to repeal the Cadillac tax. And, we finally have a Congressional Budget Office (CBO) score for…

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: July 12, 2019

This Week’s Dose: Congress is back for the final legislative session before the August recess, and it’s all about what can get done ahead of the break. House and Senate committees have already advanced a cost containment legislation that includes surprise billing and prescription drug cost provisions, among many other things. We still await any…

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: June 28, 2019

This Week’s Dose: Lots of movement in Congress ahead of the Fourth of July recess with the House and Senate both advancing a number of health care bills. President Trump also signed an executive order this week, continuing the Administration’s focus on health care transparency.

POST

Insight: original analysis

McDermottPlus Check-Up: June 14, 2019

This Week’s Dose: The focus was back on surprise billing this week with the third hearing of the year. We also saw hearings on Medicare for All and vertical consolidation in the health care industry, and the House advanced an appropriations package.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: May 10, 2019

This Week’s Dose: Another busy week for prescription drug pricing. Two more hearings took place on the subject, and a handful of bills passed out of the House. Now we watch the Senate to see how it packages and advances prescription drug bills that have moved through the House.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: April 26, 2019

This Week’s Dose: When Congress is away, the agencies will play. The Administration made some major announcements and dropped several new important rules this week, giving stakeholders plenty to talk about (and work on) while Congress is in recess.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: April 12, 2019

This Week’s Dose: Drug pricing continues to be the focus in Congress with multiple hearings and markups on the subject. So far, lowering drug prices remains a rare area of consensus among lawmakers.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: April 5, 2019

This Week’s Dose: Health care continues to dominate much of the attention on Capitol Hill. Lots of hearings. New coverage expansion legislation. And more state action on Medicaid.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: February 15, 2019

This Week’s Diagnosis: Congress passed a $328 billion spending package to avert another government shutdown.  President Trump is expected to sign it.  Congressional hearings continue to focus on coverage and drug pricing.  

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: February 8, 2019

This Week’s Dose: The State of the Union briefly highlighted a few Administration health initiatives. The House continues its focus on the Affordable Care Act (ACA). The Senate is pressuring CEOs from the largest drug manufacturers to testify.  

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: January 11, 2019

This Week’s Diagnosis: Welcome back – sort of. The partial federal government shutdown drags on. We are on day 21 with no end in sight, which has shifted the focus of the new Congress away from overarching health priorities and toward continued efforts to reopen the government.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: December 21, 2018

This Week’s Diagnosis: Time is ticking for any deal to avoid any partial government shutdown. It is the only thing holding up adjournment.

POST

Insight: original analysis

McDermottPlus Check-Up: November 30, 2018

This Week’s Diagnoses: Welcome back! Members are back in town for a sprint to the finish. Controversy over the House Democratic leadership elections fizzled, with the same faces in the top three positions.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: November 9, 2018

This Week’s Diagnoses: Was the election only four days ago? Tuesday brought change to Congress. While a handful of races have yet to be called, Democrats will take charge of the House of Representatives, while Republicans will retain control of the Senate come January 2019. We have a full breakdown of what the election results…

ORIGINAL ANALYSIS

Insight: original analysis

Election Results Bring Change in Health Priorities

Democrats will take control of the House of Representatives in January 2019. Republicans will retain control of the Senate, widening their margin slightly. Split control of Congress will have important consequences for healthcare policy.  This article takes a closer look at how the election is likely to impact the health policy agenda.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: November 2, 2018

This Week’s Diagnosis: While members of Congress are touting the passage of the opioid package on the campaign trail, the Administration continued releasing a series of significant health policy regulations.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: October 26, 2018

This Week’s Diagnosis: The Administration remains active with the issuance of several new guidance documents, the drug pricing announcement and the President (finally) signing the bipartisan opioid legislation (HR 6).

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: October 5, 2018

This Week’s Diagnosis: The Senate continues to chug along with hearings, opioids and judicial nominees. All is quiet in DC on the House side – members are in their home districts campaigning for re-election.

ORIGINAL ANALYSIS

Insight: original analysis

Senate Republicans Released an ACA Repeal and Replace Bill Discussion Draft, the “Better Care Reconciliation Act of 2017,” on June 22, 2017

A McDermottPlus side-by-side comparison table reflecting the draft’s major proposals compared to the AHCA and the ACA is now available

ORIGINAL ANALYSIS

Insight: original analysis

Briefing Points for the Board – The Election and the 2017 Health Policy Agenda

It is vitally important for the health system board, as well as certain of its key committees, to receive an introductory briefing as soon as possible on the health policy implications of last week’s Presidential and Congressional elections, as they are currently understood.

ORIGINAL ANALYSIS

Load more
beakernav X1E2BFA62-BFCE-43C1-B777-27E3E5216018medical bagoriginal analysis +external linkpdf downloadstethoscope